Hexavest Inc. - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 336 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2019. The put-call ratio across all filers is 1.03 and the average weighting 0.3%.

Quarter-by-quarter ownership
Hexavest Inc. ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2019$20,0000.0%1,1340.0%0.00%
Q2 2019$20,000
-13.0%
1,1340.0%0.00%
Q1 2019$23,000
+21.1%
1,1340.0%0.00%
Q4 2018$19,000
-20.8%
1,1340.0%0.00%
Q3 2018$24,0000.0%1,1340.0%0.00%
Q2 2018$24,000
-14.3%
1,1340.0%0.00%
Q1 2018$28,000
-12.5%
1,1340.0%0.00%
Q4 2017$32,000
+3.2%
1,1340.0%0.00%
Q3 2017$31,000
+6.9%
1,1340.0%0.00%
Q2 2017$29,000
+7.4%
1,1340.0%0.00%
Q1 2017$27,000
+12.5%
1,1340.0%0.00%
Q4 2016$24,000
-11.1%
1,1340.0%0.00%
Q3 2016$27,000
+12.5%
1,1340.0%0.00%
Q2 2016$24,000
-7.7%
1,1340.0%0.00%
Q1 2016$26,000
-7.1%
1,1340.0%0.00%
Q4 2015$28,000
+12.0%
1,1340.0%0.00%
Q3 2015$25,000
-7.4%
1,1340.0%0.00%
Q2 2015$27,000
-3.6%
1,1340.0%0.00%
Q1 2015$28,000
+16.7%
1,1340.0%0.00%
Q4 2014$24,000
-4.0%
1,1340.0%0.00%
Q3 2014$25,000
-3.8%
1,1340.0%0.00%
Q2 2014$26,000
-3.7%
1,1340.0%0.00%
Q1 2014$27,000
+3.8%
1,1340.0%0.00%
Q4 2013$26,000
-3.7%
1,1340.0%0.00%
Q3 2013$27,000
+3.8%
1,1340.0%0.00%
Q2 2013$26,0001,1340.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q4 2019
NameSharesValueWeighting ↓
Adelphi Capital LLP 9,270,535$188,841,00039.13%
Sachem Head Capital 5,963,600$121,479,0007.38%
NINE MASTS CAPITAL Ltd 1,049,886$21,415,0006.68%
Paulson & Co. 26,489,422$539,590,0005.77%
Blackcrane Capital, LLC 189,549$3,861,0005.16%
Glenview Capital Management 26,112,660$531,915,0004.75%
Exane Asset Management 430,369$8,766,617,0004.26%
Velanne Asset Management Ltd 281,972$5,744,0003.97%
Bluefin Trading, LLC 1,204,702$24,540,0003.55%
Endurant Capital Management LP 437,436$8,911,0003.52%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders